Fabien Schmidlin, Global Head of Translational Medicine at Servier joined the Group in 2019.
With a PhD in Molecular Pharmacology from the University of Strasbourg and then a post Doc at USCF in San Francisco, Fabien joined the pharmaceutical industry where he held R&D responsibilities covering different therapeutic areas in Oncology- Endocrinology-Inflammation-Neurology.
Fabien started his career at Pfizer in France, then joined Astra Zeneca in the UK, and Merck Serono in France.
Before joining Servier, Fabien was VP Translational Sciences & Clinical Pharmacology at IPSEN.